Updated: 4 min 18 sec ago
Software helps the global biopharmaceutical company’s Cotia plant quickly review 3D models of new packaging for internal customers.
MiR100 offers flexibility, efficiency and cost effectiveness, providing an option to automated guided vehicles.
Wood pallets paving the way as economic expansion boosts demand in the materials transport segment.
The federal Medicare agency recommends use of ID numbers to help detect malfunctions in devices.
Lounges provide exhibitors and PMMI members a haven away from show floor.
New offerings support paper and packaging categories across the U.S., South America and Latin America.
Visiongain report cites increasing demand for blister packaging, anti-counterfeiting technology, online printing and R&D investments in certain therapeutic areas as growth factors in pharmaceutical packaging.
The Swiss-based pharma giant looks to compensate for expired patents on blockbuster drugs by doubling down on biosimilars.
Novel Laboratories recalls Zolpidem Tartrate blister packs; U.S. CPSC says it poses poisoning risk if swallowed by children.
Version 2.0 of company’s Open SiteMaster™ site server software developed in collaboration with pharmaceutical industry and contract packers.
GenPak Solutions cited for CGMP violations at Ohio facility.
New 32-page catalog lists hundreds of products for plastic and metal storage, organization, transport and material handling products.
Print & Check Flex serialization unit provides flexibility to contract packagers requiring flexibility in carton dimensions, artwork changes and varying code printing specifications.
Thermal packaging leader and biopharma industry resource conduct industry-wide study to benchmark methods used to maintain efficacy of temperature-sensitive therapeutics throughout the supply chain.
Here’s a review of the different methods of coming clean.
A new pediatric trend seeks more accurate results by easing stress on young subjects.
Dutch start-up company launches pallet that combines new materials with the Internet of Things.
Agency welcomes comments and suggestions to draft document within 60 days of publication in the Federal Register.
ECRI claims only 5% of the 60,000 genetic tests out there are clinically relevant.
Key Intl. becomes exclusive North American distributor of IMAR’s vertical form/fill/seal equipment for multiple end-use markets.